Cannabinoids May Improve Appetite, Behavior in Dementia

For patients with dementia, cannabinoids may be a promising intervention for treating neuropsychiatric symptoms (NPS) and the refusing of food,

Read more

Blood Pressure Meds Tied to Increased Schizophrenia Risk

Angiotensin-converting enzyme (ACE) inhibitors may be associated with an increased risk for schizophrenia and may affect psychiatric symptoms, new research

Read more

Psychosis, delirium: Scientists warn of potential wave of Covid-linked brain damage

Scientists warned on Wednesday of a potential wave of coronavirus-related brain damage as new evidence suggested COVID-19 can lead to

Read more